A group of researchers showed that there is symbiosis between cannabidiol (CBD) and 3 antibiotics (ampicillin, kanamycin and polymyxin B) for the treatment of salmonella.
Salmonella is harmfull bacterium that can be harmful. This bacterium dangerous if infected.
According to researchers at the School of Science, Technology, Engineering and Mathematics at the University of Alabama, Montgomery, CBD is one of the most promising new classes of antibiotics.
“It is a non-toxic, low-resistance chemical that can be used to treat bacterial infections,” the study says.
The study was intended to study the possibilities CBD has against a wide variety of bacterial species and their interactions with common therapies.
“This study demonstrates that CBD-antibiotic cotherapy (combination of CBD and antibiotic) can effectively combat Salmonella typhimurium (S. typhimurium) through disruption of membrane integrity,” the researchers note.
The study also reveals that the growth of S.Typhimurium is inhibited at very low doses of CBD antibiotic. The researchers conclude that CBD may be a new class of novel and useful antibiotics for these effects.